⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 27, 2015Journal of Experimental & Clinical Cancer ResearchOpen Access

Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer

Satoshi Nishiwada Masayuki Sho Satoshi Yasuda Keiji Shimada Ichiro Yamato Takahiro Akahori Shoichi Kinoshita Minako Nagai Noboru Konishi Yoshiyuki Nakajima

View Full Paper

Ask AI

Bookmark

Share

Abstract

Nectin-4 is a significant prognostic predictor, and may play a critical role in pancreatic cancer. Nectin-4 may be novel therapeutic target for pancreatic cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nishiwada et al. (2015) studied this question.

synapsesocial.com/papers/69dabf804e9a02dbaa68446f https://doi.org/10.1186/s13046-015-0144-7

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cancer statistics, 2014Original Research · 2014 · 11,505 citations
2Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupRCT · 2007 · 3,851 citations
3FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerOriginal Research · 2011 · 7,800 citations
4Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II TrialLate-Phase Clinical Trial · 2011 · 1,045 citations
5Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyLate-Phase Clinical Trial · 2013 · 629 citations

<i>nab</i> -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer2012
Validation of a Postresection Pancreatic Adenocarcinoma Nomogram for Disease-Specific Survival2005
Molecular markers associated with outcome and metastasis in human pancreatic cancer2012
Spatial transcriptomics identifies a B cells–depleted profile underlying high-risk classical Hodgkin LymphomaJournal of Experimental & Clinical Cancer Research · 2026
Development of gemcitabine-modified miR-15a as a novel, multimodal treatment strategy to overcome 5-FU and oxaliplatin resistance in colorectal cancerJournal of Experimental & Clinical Cancer Research · 2026

More from Journal of Experimental & Clinical Cancer Research

More from Nara Medical University